Atlas Trials

Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)

Clinical trial NCT00079027 · UNKNOWN

Trial details

NCT number
NCT00079027
Sponsor
University Hospital Birmingham
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Liver Cancer
Start date
2004-04-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.